發送短信 : Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

  ____     __   __    ____     _    _     _____   
 |  _ \\   \ \\/ //  |  _ \\  | || | ||  /  ___|| 
 | |_| ||   \ ` //   | |_| || | || | || | // __   
 | .  //     | ||    | .  //  | \\_/ || | \\_\ || 
 |_|\_\\     |_||    |_|\_\\   \____//   \____//  
 `-` --`     `-`'    `-` --`    `---`     `---`